Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience Defers by One Year $2M Payment to Sirius in Biomarker Agreement

NEW YORK (GenomeWeb News) — Tm Bioscience today said it has amended its licensing agreement with Sirius Genomics to defer a $2 million payment that was due Sept. 5 until sometime in October 2007, or “90 days after completion of certain milestones by Sirius.”
 
Tm Bioscience’s patented materials include an FDA approved genotyping test for cystic fibrosis, as well as other tests based on the company’s Tag-it Universal Array platform.
 
Sirius works to identify biological pathways that may help to improve study design and assist in the selection of candidates for clinical trials.
 
The agreement deals with diagnosis concerning protein C and arginine vasopressin.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.